Various systemic factors combine to keep prescription drug prices elevated across the United States.
The high cost of prescription drugs in the U.S. stems from a complex interplay of factors including minimal government price regulation, patent protections that limit generic competition, and substantial research and development expenses. Additionally, the involvement of intermediaries like pharmacy benefit managers and the fragmented nature of the healthcare system contribute to inflated prices. Understanding these elements is essential for grasping how medication costs impact consumers nationwide.
